ARCHIVES

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

This article is from The Cancer Letter archive.

Vol. 23 No. 36 | September 19, 1997

Download PDF Visit The Full Archive

Related Articles

Sharfstein To Leave FDA

January 7, 2011

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012